Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours

被引：0
|
作者：
Hallet, Julie [1 ,2 ]
Soreide, Kjetil [3 ,4 ,5 ]
机构：
[1] Univ Toronto, Dept Surg, 2075 Bayview Ave,T2-102, Toronto, ON M4N 3M5, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Div Surg Oncol, Susan Leslie Clin Neuroendocrine Tumours, Toronto, ON, Canada
[3] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway
[4] Stavanger Univ Hosp, Lab Mol Med, Gastrointestinal Translat Res Grp, Stavanger, Norway
[5] Univ Bergen, Dept Clin Med, Bergen, Norway
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 09期
关键词：
D O I：
10.1093/bjs/znae183
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
    da Silva, Tiago Nunes
    van Velthuysen, M. L. F.
    van Eijck, Casper H. J.
    Teunissen, Jaap J.
    Hofland, J.
    de Herder, Wouter W.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2018,
  • [12] Peptide Receptor Radionuclide Therapy in Rectal Neuroendocrine Tumours
    Tham, W. Y. A.
    Huang, H. L.
    Tai, W. M. D.
    Yan, X. S.
    Ng, C. E. D.
    Loke, S. H. K.
    NEUROENDOCRINOLOGY, 2020, 110 : 275 - 275
  • [13] Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
    Partelli, Stefano
    Bertani, Emilio
    Bartolomei, Mirco
    Perali, Carolina
    Muffatti, Francesca
    Grana, Chiara Maria
    Lena, Marco Schiavo
    Doglioni, Claudio
    Crippa, Stefano
    Fazio, Nicola
    Zamboni, Giuseppe
    Falconi, Massimo
    SURGERY, 2018, 163 (04) : 761 - 767
  • [14] Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
    Sowa-Staszczak, Anna
    Pach, Dorota
    Chrzan, Robert
    Trofimiuk, Malgorzata
    Stefanska, Agnieszka
    Tomaszuk, Monika
    Kolodziej, Maciej
    Mikolajczak, Renata
    Pawlak, Dariusz
    Hubalewska-Dydejczyk, Alicja
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (09) : 1669 - 1674
  • [15] Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
    Anna Sowa-Staszczak
    Dorota Pach
    Robert Chrzan
    Małgorzata Trofimiuk
    Agnieszka Stefańska
    Monika Tomaszuk
    Maciej Kołodziej
    Renata Mikołajczak
    Dariusz Pawlak
    Alicja Hubalewska-Dydejczyk
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38
  • [16] Editorial: peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms
    Pommier, Rodney F.
    SURGERY, 2018, 163 (04) : 768 - 769
  • [17] Importance of peptide receptor radionuclide therapy for the management of neuroendocrine tumours
    Ciuciulkaite, I.
    Herrmann, K.
    Lahner, H.
    ONKOLOGIE, 2024, 30 (11): : 1065 - 1074
  • [18] Peptide Receptor Radionuclide Therapy (PRRT) a Novel Option as Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors: A Surgical Series
    Miotto, M.
    Nessi, C.
    Cingarlini, S.
    Severi, S.
    Paganelli, G.
    Malleo, G.
    D'Onofrio, M.
    Pea, A.
    Vincenzi, S.
    Scarpa, A.
    Salvia, R.
    Landoni, L.
    NEUROENDOCRINOLOGY, 2019, 108 : 254 - 254
  • [19] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
    Potter, Samara
    Johnston, Danielle
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [20] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Samuel Adant
    Girish M. Shah
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 907 - 921
12345